Literature DB >> 5429655

Increased release of gut glucagon in reactive hypoglycaemia.

J F Rehfeld, L G Heding.   

Abstract

A patient with reactive hypoglycaemia showed hypersecretion of insulin in response to enteral beta-cell stimulation. Increased levels of gut glucagon-like immunoreactivity in serum were demonstrated by use of specific antisera. Other measurable hormones influencing carbohydrate metabolism were within normal limits. It is suggested that gut glucagon-like immunoreactivity may be of pathogenetic significance in reactive hypoglycaemia.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5429655      PMCID: PMC1700662          DOI: 10.1136/bmj.2.5711.706

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  9 in total

1.  Spontaneous hypoglycemia.

Authors:  J W CONN; H S SELTZER
Journal:  Am J Med       Date:  1955-09       Impact factor: 4.965

2.  A simplified technique for the determination of growth hormone dependent sulfation factor, using intact animals.

Authors:  H Yde
Journal:  Acta Endocrinol (Copenh)       Date:  1968-04

3.  Pathophysiology of post-gastrectomy hypoglycaemia.

Authors:  C D Holdsworth; D Turner; N McIntyre
Journal:  Br Med J       Date:  1969-11-01

4.  New ideas concerning the physiologic roles of glucagon.

Authors:  R H Unger
Journal:  Am J Med Sci       Date:  1968-05       Impact factor: 2.378

5.  Intestinal factors in the control of insulin secretion.

Authors:  N McIntyre; C D Holdsworth; D S Turner
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

6.  Plasma insulin levels during reactive hypoglycemia.

Authors:  K E Sussman; L Stimmler; H Birenboim
Journal:  Diabetes       Date:  1966-01       Impact factor: 9.461

7.  Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose.

Authors:  R H Unger; A Ohneda; I Valverde; A M Eisentraut; J Exton
Journal:  J Clin Invest       Date:  1968-01       Impact factor: 14.808

8.  Effects of secretin, pancreozymin, or gastrin on the response of the endocrine pancreas to administration of glucose or arginine in man.

Authors:  J Dupre; J D Curtis; R H Unger; R W Waddell; J C Beck
Journal:  J Clin Invest       Date:  1969-04       Impact factor: 14.808

9.  The gastrointestinal stimulus to insulin release. I. Secretin.

Authors:  D J Chisholm; J D Young; L Lazarus
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

  9 in total
  4 in total

1.  Identification of glucagon in the gastrointestinal tract.

Authors:  H Sasaki; B Rubalcava; D Baetens; E Blazquez; C B Srikant; L Orci; R H Unger
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

2.  Increased glucose disposal after jejuno-ileostomy.

Authors:  J F Rehfeld; K B Lauritsen; J J Holst
Journal:  Diabetologia       Date:  1979-01       Impact factor: 10.122

3.  The glucagon-like polypeptides - order out of chaos?

Authors:  J M Conlon
Journal:  Diabetologia       Date:  1980       Impact factor: 10.122

4.  The effects of glucagon, secretin, pancreozymin and pentagastrin on the hepatic arterial vascular bed of the dog.

Authors:  P D Richardson; P G Withrington
Journal:  Br J Pharmacol       Date:  1977-01       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.